Dec 15, 2025
How to Keep a Medication List for Safer Care and Fewer Errors
Different medication classes-prescription, OTC, and herbal-come with unique side effect risks. Learn how to spot dangerous interactions, why generic switches matter for some drugs, and how to stay safe with every pill you take.
Learn how to track global medication safety alerts, report side effects effectively, and use trusted resources like WHO, UMC, and the Yellow Card system to protect patients and stay ahead of emerging drug risks.
Learn how to prevent dangerous errors in customized medications through dual verification, proper labeling, cleanroom standards, and accreditation. Essential safety steps for pharmacists and patients alike.
Bioequivalent medications are generic drugs proven to work the same as brand-name versions in your body. Learn how the FDA tests for equivalence, why it matters, and when to ask questions.
Tirzepatide (Zepbound) is a dual incretin therapy that targets GLP-1 and GIP receptors for significant weight loss. Learn how it works, what to expect, side effects, cost, and real results from clinical trials and patient experiences.
Five practical, evidence-based medication safety tips for seniors and caregivers to prevent dangerous drug interactions, missed doses, and hospitalizations. Backed by the FDA and geriatric experts.
The FDA now enforces strict, unannounced inspections on foreign generic drug factories to ensure safety. Learn how CGMP standards, inspection gaps, and new policies are reshaping global drug manufacturing for American patients.
Levothyroxine is effective for hypothyroidism, but safety depends on proper dosing and regular TSH monitoring. Brand switches, missed tests, and poor timing can cause serious side effects. Know how to protect yourself.
Generic drug exclusivity periods vary widely across countries, affecting drug prices and access. Learn how the U.S., EU, Canada, and others regulate generic entry and why these rules matter for patients and healthcare systems.
The FDA's 2025 update to biosimilar approval rules removes outdated clinical trial requirements, speeding up access to lower-cost biologic alternatives for cancer, arthritis, and other chronic conditions.
